Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)

Navas-Acien, A., Santella, R. M., Joubert, B. R., Huang, Z., Lokhnygina, Y., Ujueta, F., Gurvich, I., LoIacono, N. J., Ravalli, F., Ward, C. D., Jarrett, J. M., Salazar, A. D. L., Boineau, R., Jones, T. L. Z., Mark, D. B., Newman, J. D., Nathan, D. M., Anstrom, K. J., & Lamas, G. A. (2024). Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2). American Heart Journal, 273, 72–82. https://doi.org/10.1016/j.ahj.2024.04.005
Authors:
Ana Navas-Acien
Regina M Santella
Bonnie R Joubert
Zhen Huang
Yuliya Lokhnygina
Francisco Ujueta
Irina Gurvich
Nancy J LoIacono
Filippo Ravalli
Cynthia D Ward
Jeffery M Jarrett
Alfonsina De Leon Salazar
Robin Boineau
Teresa L Z Jones
Daniel B Mark
Jonathan D Newman
David M Nathan
Kevin J Anstrom
Gervasio A Lamas
Affiliated Authors:
Ana Navas-Acien
Regina M Santella
Irina Gurvich
Nancy J LoIacono
Filippo Ravalli
Gervasio A Lamas
Subjects:
Publication Type:
Article
Unique ID:
10.1016/j.ahj.2024.04.005
PMID:
Publication Date:
Data Source:
PubMed

Record Created: